Carlos Donolo

Carlos Donolo is the technical director of Filaxis Farmacéutica S.A., a company recently penalized by ANMAT for significant breaches in quality control and manufacturing practices. He is currently under investigation as part of a sanitary inquiry following the withdrawal of several oncology medications from the market due to critical production failures.